European generic drug companies ask EU Parliament to remove patents from ACTA
The European Generics Association has written to the European Parliament asking that patents be removed from the Anti-Counterfeiting Agreement. A PDF copy of their letter is here. The text in html follows:
MEP Mr. Gianluca Susta
INTA Committee
European Parliament
1049 Bruxelles- BelgiumBrussels, 5th of November 2010
Ref. EGA comments to the consolidated text on ACTA that reflects changes made during the
September 2010 Tokyo round1.
Dear Mr. Susta,
Statement of the United States to WTO TRIPS Council on the Paragraph 6 System
The following statement was delivered by USTR at the WTO Council for TRIPS Annual Review of the Paragraph 6 System on Wednesday, 27 October 2010.
Statement of the United States
Agenda item F, Annual Review of the Paragraph 6 System
Topic 5Mr. Chairman
We are pleased to be here today to participate in the annual review on the implementation of paragraph 6 of the Doha Declaration.
The 2010 US elections
This was originally published in the Huffington Post here.
————
Continue ReadingRemarks by UNAIDS Secretariat and on behalf of UNDP: Capacity building on the Paragraph 6 System and related TRIPS flexibilities
The following statement was delivered on Wednesday, 27 October 2010 by the UNAIDS Secretariat and on behalf of UNDP during the Annual Review of Paragraph 6.
World Trade Organization
Council for TRIPS – Regular Session
Annual Review of Paragraph 6
Doha Declaration on the TRIPS Agreement and Public Health
Agenda item 4 – Capacity building on the Paragraph 6 System and related TRIPS flexibilities
Remarks by UNAIDS Secretariat and on behalf of UNDP
27 October 2010
Mr Chair, Distinguished Delegates
Paragraph 6 system: Brazilian intervention at the WTO TRIPS Council
On Wednesday, 27 October 2010, Brazil delivered the following intervention during the annual review of the Paragraph 6 system at the WTO TRIPS Council. The Brazilian intervention followed Canada’s detailed explanation of her use of the Paragraph 6 system in the Apotex/Rwanda case. The Brazilian intervention voiced concern over the future prospects of access to competitively priced second and third line ARVs raising questions as to whether the Paragraph 6 system would be economically viable for generic producers.
KEI Letter to the European Parliament regarding ACTA, October 25, 2010
(A PDF version of this is available here.)
Knowledge Ecology International
October 25, 2010
Letter to the European Parliament regarding ACTA
KEI’s ACTA timeline
ACTA Timeline
2007
- September 24 to October 3, 2007, WIPO General Assembly meets and approves the WIPO Development Agenda.
- October 23, 2007. Joint announcement is made regarding the formal launch of negotiations on ACTA. The USTR announcement is here.
2008
Statement of the Holy See at 48th WIPO General Assembly
48th Series of Meetings of the World Intellectual Property Organization’s General Assemblies
Statement by H.E. Archbishop Silvano M. Tomasi, Permanent Representative of the Holy See to the United Nations and Other International Organizations in Geneva
at the 48th Series of Meetings of the World Intellectual Property Organization’s General Assemblies
Geneva, 21 September 2010
Mr. President,
Access to Orphan Works, and ACTA provisions on damages
Access to Orphan Works, and ACTA provisions on damages
KEI Policy Brief 2010: 1
20 October 2010Introduction
Copyright is a term that in the United States describes the laws that regulate the use and distribution of “original works of authorship.” The types of activities and expressions protected by copyright have expanded over the years, particularly due to technology, but also due to the lobbying by various interested parties. The current systems of registration of copyrighted works in the United includes the following catagories:
Statement by the EU and its Member States on the preliminary study on standards and patents (SCP/13/2)
STANDING COMMITTEE ON THE LAW OF PATENTS
15th Session
(Geneva, 11 to 15 October 2010)Statement by the EU and its Member States on the preliminary study on standards and patents (SCP/13/2)Mr. Chairman,